SEC Form 4 · accession 0001179110-18-003678
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne R Swanton
Officer — EVP, Global Operations
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 6:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2 | Mar 2, 2018 | F | 58 | $144.02 | D | 16,899 | D | |
| Ordinary Shares, par value $0.0001F1 | Mar 5, 2018 | F | 150 | $148.73 | D | 16,749 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- F2Includes 6,072 ordinary shares inadvertantly omitted from Mr. Swanton's Form 3 filed on January 19, 2018.